Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes — Kirk Magee (2001) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes
Shared by
David Moher
Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes
Article
2001
en
Authors
+1 more
KM
Kirk Magee
BR
Brian Rowe
David Moher
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Article
2003
Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes
Kirk Magee
,
William W Sevcik
,
David Moher
,
Brian H. Rowe
Article
1995
Treatment of venous thromboembolism: unfractionated heparin or low molecular weight heparins?
Giancarlo Agnelli
Article
2008
Heparin versus placebo for acute coronary syndromes
Kirk Magee
,
Samuel Campbell
,
David Moher
,
Brian H. Rowe
Article
2010
Heparin versus placebo for acute coronary syndromes (Review)
Kirk Magee
,
Campbell Sg
,
David Moher
,
Rowe Bh
Article
2003
Combination therapy with low-molecular-weight heparin and glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: insights from the Global Registry of Acute Coronary Events (GRACE)
Giancarlo Agnelli
,
C. P. Cannon
,
Frans Van de Werf
,
Álvaro Avezum
,
Gilles Montalescot
,
Wolfgang Lankes
,
BM Kennelly
,
Tomasz Mazurek
,
Rachel Kasper
,
David Brieger
.webp)
Discussion(0)
No comments yet. Be the first to comment.